Showing results (11-20 of 75) with videos related to
Sort By:
Pageof 8
European Journal of Medicinal Chemistry|July 9, 2017
Synthesis of sulfamoylbenzamide derivatives as HBV capsid assembly effectorOzkan Sari, Sebastien Boucle, Bryan D Cox, et al.Virology|April 9, 2016
Characterization of dengue virus 2 growth in megakaryocyte-erythrocyte progenitor cellsKristina B Clark, Hui-Mien Hsiao, Leda Bassit, et al.Bioorganic & Medicinal Chemistry Letters|January 18, 2017
Synthesis and antiviral evaluation of novel heteroarylpyrimidines analogs as HBV capsid effectorsSebastien Boucle, Xiao Lu, Leda Bassit, et al.Antimicrobial Agents and Chemotherapy|September 19, 2012
Evaluation of single and combination therapies with tenofovir disoproxil fumarate and emtricitabine in vitro and in a robust mouse model supporting high levels of hepatitis B virus replicationRaymond F Schinazi, Leda Bassit, Marcia M Clayton, et al.Nucleosides, Nucleotides & Nucleic Acids|October 21, 2016
Synthesis and antiviral evaluation of fluorinated acyclo-nucleosides and their phosphoramidatesSawsan Mahmoud, Hao Li, Tamara R McBrayer, et al.RSC Advances|October 4, 2021
Novel 1'-homo-N-2'-deoxy-α-nucleosides: synthesis, characterization and biological activityAlejandro Carnero, Virginia Martín-Nieves, Yogesh S Sanghvi, et al.Molecules (Basel, Switzerland)|March 15, 2020
Synthesis of 4'-Substituted-2'-Deoxy-2'-α-Fluoro Nucleoside Analogs as Potential Antiviral AgentsMahesh Kasthuri, Chengwei Li, Kiran Verma, et al.Chemical Biology & Drug Design|March 21, 2022
In silico design of a novel nucleotide antiviral agent by free energy perturbationDharmeshkumar Patel, Bryan D Cox, Mahesh Kasthuri, et al.Infection and Drug Resistance|March 14, 2014
Approaches to hepatitis C treatment and cure using NS5A inhibitorsJames J Kohler, James H Nettles, Franck Amblard, et al.Tetrahedron Letters|February 7, 2017
Synthesis and antiviral evaluation of 2',2',3',3'-tetrafluoro nucleoside analogsOzkan Sari, Leda Bassit, Christina Gavegnano, et al.Pageof 8